Professor claims Eli Lilly's tirzepatide could essentially eradicate type 2 diabetes
Professor and consultant Sten Madsbad says that the treatment could be a new start for type 2 diabetes sufferers.
by andreas lønstrup, translated by catherine brett
Eli Lilly’s tirzepatide is ”a new start” within type 2 diabetes and could essentially eradicate the disease, professor Sten Madsbad, who is a consultant at the endocrinology department at Hvidovre hospital, tells Danish journal Sundhedspolitisk Tidsskrift.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Eli Lilly squares up to Novo Nordisk on obesity market
For subscribers
